Anebulo Pharmaceuticals, Inc. (ANEB) stock

ANEBNasdaqPharmaceutical PreparationsFiscal year ends June 30

Financials through Q2 FY2026, quarter ended Dec 31, 2025Last filing: 10-Q on Feb 12, 2026Score 0/30

$0.00+0.00 (+75.00%)

Close on Oct 19, 2026Market cap $28.76KP/E –Yield –

Anebulo Pharmaceuticals ebitda

EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.

Anebulo Pharmaceuticals has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

See a number that looks wrong?